WELA:XETRA:XETRA-Amundi MSCI ACWI SRI PAB UCITS ETF DR USD Acc EUR (EUR)

ETF | Others |

Last Closing

USD 11.804

Change

0.00 (-0.02)%

Market Cap

USD 0.08B

Volume

6.84K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.10 (-0.19%)

USD 548.90B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.05 (-0.30%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.03 (-0.09%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.04 (-0.14%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.03 (+0.10%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-2.02 (-1.32%)

USD 103.20B
JARI:XETRA Amundi Index Solutions - Amund..

-0.06 (-0.13%)

USD 102.92B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.12 (-0.23%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-2.52 (-0.46%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.07 (-0.28%)

USD 79.79B

ETFs Containing WELA:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.09% 66% D+ 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.09% 65% D 65% D
Trailing 12 Months  
Capital Gain 16.14% 62% D 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.14% 61% D- 62% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.67% 56% F 55% F
Dividend Return 5.67% 55% F 53% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.59% 68% D+ 75% C
Risk Adjusted Return 74.68% 85% B 86% B+
Market Capitalization 0.08B 30% F 27% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.